Wiedemann K, Holsboer F
Max Planck Institute of Psychiatry, Munich, Germany.
Biol Psychiatry. 1997 Nov 15;42(10):882-8. doi: 10.1016/S0006-3223(96)00434-9.
A dexamethasone suppression test (DST) using a dosage of 1.5 mg dexamethasone was administered two times in randomized order to 10 healthy male subjects. From 2300 hours to 0700 hours subjects were injected repeatedly with either increasing dosages of human corticotropin-releasing hormone (hCRH) or 0.9% saline. In comparison to saline administration, in which cortisol levels remained suppressed, the time course of cortisol concentrations with hCRH stimulation showed a biphasic secretory pattern. According to a criterion level of a minimum of 40 ng/mL plasma for nonsuppression, the majority of the subjects changed their DST status to nonsuppression with hCRH. Adrenocorticotropic hormone secretion also differed significantly between saline and hCRH administration. During stimulation with hCRH, plasma dexamethasone levels were slightly and nonsignificantly reduced in the morning hours. Our results indicate that repeated dosages of hCRH impair the dexamethasone-induced suppression in man and support an involvement of CRH also in mediation of the DST nonsuppression during depressive illness.
对10名健康男性受试者按随机顺序进行了两次地塞米松抑制试验(DST),地塞米松剂量为1.5毫克。从23:00至07:00,受试者被反复注射递增剂量的人促肾上腺皮质激素释放激素(hCRH)或0.9%生理盐水。与生理盐水注射后皮质醇水平仍受抑制相比,hCRH刺激下皮质醇浓度的时间进程呈现双相分泌模式。根据非抑制时血浆最低40纳克/毫升的标准水平,大多数受试者在接受hCRH后其DST状态变为非抑制。生理盐水和hCRH注射时促肾上腺皮质激素分泌也有显著差异。在hCRH刺激期间,早晨时段血浆地塞米松水平略有下降,但无显著差异。我们的结果表明,重复剂量的hCRH会损害地塞米松在人体中诱导的抑制作用,并支持CRH也参与抑郁症期间DST非抑制的介导过程。